AZ Delta uw Ziekenhuis Campus Rumbeke, campus Brugsesteenweg Roeselare
- Address
- lock Available on a paid plan
AZ Delta - Campus Rumbeke Cardiovascular and Oncology Research Center
AZ Delta Campus Rumbeke in Roeselare is a distinguished medical research facility conducting advanced clinical investigations in cardiovascular medicine and oncology. The center demonstrates particular expertise in evaluating novel therapeutic strategies and device innovations that aim to improve patient outcomes while optimizing treatment safety profiles.
- Neuroendocrine tumor management and progression strategies
- Coronary artery disease and interventional cardiology device trials
- Antiplatelet therapy optimization and bleeding risk reduction
The research program at AZ Delta encompasses sophisticated studies in neuroendocrine tumours, investigating the continuation of somatostatin analogues upon disease progression and their impact on patient quality of life. In cardiovascular research, the center actively evaluates cutting-edge coronary stent technologies and explores abbreviated dual antiplatelet therapy regimens to balance efficacy with reduced bleeding complications in patients with coronary artery disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1St. Antonius Ziekenhuis1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in AZ Delta uw Ziekenhuis Campus Rumbeke, campus Brugsesteenweg Roeselare
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Continuing Somatostatin Analogues Upon progression in Neuroendocrine tumour pAtients (SAUNA trial) | Universitair Ziekenhuis Antwerpen | Phase III | Recruiting | Jun 2023 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 2 | Unknown | 2023-10-06 | 2023-12-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.